{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:25:24Z","timestamp":1791890724929,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s12325-023-02691-y","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T04:13:47Z","timestamp":1698639227000},"page":"65-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Health Economic Assessments of Hyaluronic Acid Treatments for Knee Osteoarthritis: A Systematic Review"],"prefix":"10.1007","volume":"41","author":[{"given":"Anil","family":"Ranawat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4107-7344","authenticated-orcid":false,"given":"Kaiwen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizan","family":"Niazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Waterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"issue":"7","key":"2691_CR1","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/annrheumdis-2013-204763","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1323\u201330. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204763.","journal-title":"Ann Rheum Dis"},{"key":"2691_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/bmb\/lds038","volume":"105","author":"A Litwic","year":"2013","unstructured":"Litwic A, Edwards MH, Dennison EM, Cooper C. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013;105:185\u201399. https:\/\/doi.org\/10.1093\/bmb\/lds038.","journal-title":"Br Med Bull"},{"issue":"11","key":"2691_CR3","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","volume":"27","author":"RR Bannuru","year":"2019","unstructured":"Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil. 2019;27(11):1578\u201389. https:\/\/doi.org\/10.1016\/j.joca.2019.06.011.","journal-title":"Osteoarthr Cartil"},{"issue":"6","key":"2691_CR4","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.joca.2010.09.014","volume":"19","author":"RR Bannuru","year":"2011","unstructured":"Bannuru RR, Natov NS, Dasi UR, Schmid CH, McAlindon TE. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis\u2013meta-analysis. Osteoarthr Cartil. 2011;19(6):611\u20139. https:\/\/doi.org\/10.1016\/j.joca.2010.09.014.","journal-title":"Osteoarthr Cartil"},{"issue":"12","key":"2691_CR5","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/art.24925","volume":"61","author":"RR Bannuru","year":"2009","unstructured":"Bannuru RR, Natov NS, Obadan IE, Price LL, Schmid CH, McAlindon TE. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum. 2009;61(12):1704\u201311. https:\/\/doi.org\/10.1002\/art.24925.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2691_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s13018-020-01848-7","volume":"15","author":"KL Ong","year":"2020","unstructured":"Ong KL, Niazi F, Lau E, et al. Knee OA cost comparison for hyaluronic acid and knee arthroplasty. J Orthop Surg Res. 2020;15(1):305. https:\/\/doi.org\/10.1186\/s13018-020-01848-7.","journal-title":"J Orthop Surg Res"},{"issue":"6","key":"2691_CR7","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.semarthrit.2020.01.003","volume":"50","author":"J Mackowiak","year":"2020","unstructured":"Mackowiak J, Jones JT, Dasa V. A comparison of 4-year total medical care costs, adverse outcomes, and opioid\/prescription analgesic use for 3 knee osteoarthritis pain treatments: intra-articular hyaluronic acid, intra-articular corticosteroids, and knee arthroplasty. Semin Arthritis Rheum. 2020;50(6):1525\u201334. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.01.003.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"2691_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2217\/pmt-2020-0057","volume":"10","author":"F Niazi","year":"2020","unstructured":"Niazi F, Ong KL, Kidd VD, et al. Decrease in opioid and intra-articular corticosteroid burden after intra-articular hyaluronic acid for knee osteoarthritis treatment. Pain Manag. 2020;10(6):387\u201397. https:\/\/doi.org\/10.2217\/pmt-2020-0057.","journal-title":"Pain Manag"},{"issue":"1","key":"2691_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/13696998.2021.2009710","volume":"25","author":"M Nicholls","year":"2022","unstructured":"Nicholls M, Niazi F, Nelson WW, Lau E, Kurtz SM, Ong KL. Changes in prescription pain medication and intra-articular corticosteroid utilization after intra-articular bio-fermentation derived hyaluronic acid use in patients undergoing multimodal pain management. J Med Econ. 2022;25(1):7\u201313. https:\/\/doi.org\/10.1080\/13696998.2021.2009710.","journal-title":"J Med Econ"},{"key":"2691_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jor.2020.01.020","volume":"20","author":"K Rucinski","year":"2020","unstructured":"Rucinski K, Cook JL. Effects of preoperative opioid education on postoperative opioid use and pain management in orthopaedics: a systematic review. J Orthop. 2020;20:154\u20139. https:\/\/doi.org\/10.1016\/j.jor.2020.01.020.","journal-title":"J Orthop"},{"issue":"8","key":"2691_CR11","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1177\/0363546515609599","volume":"44","author":"RD Altman","year":"2016","unstructured":"Altman RD, Bedi A, Karlsson J, Sancheti P, Schemitsch E. Product differences in intra-articular hyaluronic acids for osteoarthritis of the knee. Am J Sports Med. 2016;44(8):2158\u201365. https:\/\/doi.org\/10.1177\/0363546515609599.","journal-title":"Am J Sports Med"},{"key":"2691_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00167-019-05763-1","author":"M Phillips","year":"2020","unstructured":"Phillips M, Vannabouathong C, Devji T, et al. Differentiating factors of intra-articular injectables have a meaningful impact on knee osteoarthritis outcomes: a network meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2020. https:\/\/doi.org\/10.1007\/s00167-019-05763-1.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"2691_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-020-03729-w","author":"CD Hummer","year":"2020","unstructured":"Hummer CD, Angst F, Ngai W, et al. High molecular weight intraarticular hyaluronic acid for the treatment of knee osteoarthritis: a network meta-analysis. BMC Musculoskelet Disord. 2020. https:\/\/doi.org\/10.1186\/s12891-020-03729-w.","journal-title":"BMC Musculoskelet Disord"},{"key":"2691_CR14","doi-asserted-by":"publisher","first-page":"117954411775162","DOI":"10.1177\/1179544117751622","volume":"11","author":"M Nicholls","year":"2018","unstructured":"Nicholls M, Manjoo A, Shaw P, Niazi F, Rosen J. Rheological properties of commercially available hyaluronic acid products in the United States for the treatment of osteoarthritis knee pain. Clin Med Insights Arthritis Musculoskelet Disord. 2018;11:1179544117751622. https:\/\/doi.org\/10.1177\/1179544117751622.","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"issue":"2","key":"2691_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.joca.2005.09.003","volume":"14","author":"M Kirchner","year":"2006","unstructured":"Kirchner M, Marshall D. A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthr Cartil. 2006;14(2):154\u201362. https:\/\/doi.org\/10.1016\/j.joca.2005.09.003.","journal-title":"Osteoarthr Cartil"},{"issue":"10","key":"2691_CR16","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00296-005-0096-x","volume":"26","author":"F Atamaz","year":"2006","unstructured":"Atamaz F, Kirazli Y, Akkoc Y. A comparison of two different intra-articular hyaluronan drugs and physical therapy in the management of knee osteoarthritis. Rheumatol Int. 2006;26(10):873\u20138. https:\/\/doi.org\/10.1007\/s00296-005-0096-x.","journal-title":"Rheumatol Int"},{"issue":"4","key":"2691_CR17","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.knee.2008.02.012","volume":"15","author":"R Raman","year":"2008","unstructured":"Raman R, Dutta A, Day N, Sharma HK, Shaw CJ, Johnson GV. Efficacy of Hylan\u00a0G-F\u00a020 and sodium hyaluronate in the treatment of osteoarthritis of the knee\u2014a prospective randomized clinical trial. Knee. 2008;15(4):318\u201324. https:\/\/doi.org\/10.1016\/j.knee.2008.02.012.","journal-title":"Knee"},{"issue":"11","key":"2691_CR18","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1002\/art.23026","volume":"56","author":"P Juni","year":"2007","unstructured":"Juni P, Reichenbach S, Trelle S, et al. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee\u2014a randomized controlled trial. Arthritis Rheum. 2007;56(11):3610\u20139. https:\/\/doi.org\/10.1002\/art.23026.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2691_CR19","first-page":"213","volume":"23","author":"V Karatosun","year":"2005","unstructured":"Karatosun V, Unver B, Gocen Z, Sen A. Comparison of two hyaluronan drugs in patients with advanced osteoarthritis of the knee. A prospective, randomized, double-blind study with long term follow-up. Clin Exp Rheumatol. 2005;23(2):213\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"2691_CR20","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/s0149-2918(00)80010-7","volume":"21","author":"M Wobig","year":"1999","unstructured":"Wobig M, Bach G, Beks P, et al. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of Hyalan\u00a0G-F\u00a020 and a lower-molecular-weight hyaluronan. Clin Ther. 1999;21(9):1549\u201362. https:\/\/doi.org\/10.1016\/s0149-2918(00)80010-7.","journal-title":"Clin Ther"},{"key":"2691_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5435\/JAAOSGlobal-D-21-00203","volume":"6","author":"S Pirkle","year":"2022","unstructured":"Pirkle S, Seidel H, Bhattacharjee S, Shi LL, Lee MJ, Strelzow JA. Analysis of the cost and efficacy of intra-articular knee injections. J Am Acad Orthop Surg Glob Res Rev. 2022;6:2. https:\/\/doi.org\/10.5435\/JAAOSGlobal-D-21-00203.","journal-title":"J Am Acad Orthop Surg Glob Res Rev"},{"key":"2691_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2147\/CEOR.S347512","volume":"14","author":"M Nicholls","year":"2022","unstructured":"Nicholls M, Niazi F, Nelson WW, Lau E, Kurtz SM, Ong KL. Association between bio-fermentation derived hyaluronic acid and healthcare costs following knee arthroplasty. Clin Outcomes Res. 2022;14:575\u201385. https:\/\/doi.org\/10.2147\/CEOR.S347512.","journal-title":"Clin Outcomes Res"},{"issue":"4","key":"2691_CR23","first-page":"144","volume":"13","author":"G Malanga","year":"2020","unstructured":"Malanga G, Niazi F, Kidd VD, et al. Knee osteoarthritis treatment costs in the Medicare patient population. Am Health Drug Benefits. 2020;13(4):144\u201353.","journal-title":"Am Health Drug Benefits"},{"issue":"12","key":"2691_CR24","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1007\/s12325-016-0433-3","volume":"33","author":"J Rosen","year":"2017","unstructured":"Rosen J, Sancheti P, Fierlinger A, Niazi F, Johal H, Bedi A. Potential impact of biologically derived hyaluronic acid on quality of life in patients with knee osteoarthritis in the United States. Adv Ther. 2017;33(12):2200\u201310. https:\/\/doi.org\/10.1007\/s12325-016-0433-3.","journal-title":"Adv Ther"},{"issue":"7","key":"2691_CR25","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1055\/s-0035-1568992","volume":"29","author":"R Altman","year":"2016","unstructured":"Altman R, Fredericson M, Bhattacharyya SK, et al. Association between hyaluronic acid injections and time-to-total knee replacement surgery. J Knee Surg. 2016;29(7):564\u201370. https:\/\/doi.org\/10.1055\/s-0035-1568992.","journal-title":"J Knee Surg"},{"key":"2691_CR26","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/s12325-016-0331-8","volume":"33","author":"J Rosen","year":"2016","unstructured":"Rosen J, Sancheti P, Fierlinger A, Niazi F, Johal H, Bedi A. Cost-effectiveness of different forms of intra-articular injections for the treatment of osteoarthritis of the knee. Adv Ther. 2016;33:998\u20131011. https:\/\/doi.org\/10.1007\/s12325-016-0331-8.","journal-title":"Adv Ther"},{"issue":"17","key":"2691_CR27","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.2106\/JBJS.15.01358","volume":"98","author":"JW Weick","year":"2016","unstructured":"Weick JW, Bawa HS, Dirschl DR. Hyaluronic acid injections for treatment of advanced osteoarthritis of the knee: utilization and cost in a national population sample. J Bone Joint Surg Am. 2016;98(17):1429\u201335. https:\/\/doi.org\/10.2106\/JBJS.15.01358.","journal-title":"J Bone Joint Surg Am"},{"key":"2691_CR28","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212296","volume":"5","author":"V Dasa","year":"2016","unstructured":"Dasa V, DeKoven M, Sun K, Scott A, Lim S. Clinical and cost outcomes from different hyaluronic acid treatments in patients with knee osteoarthritis: evidence from a US health plan claims database. Drugs Context. 2016;5: 212296. https:\/\/doi.org\/10.7573\/dic.212296.","journal-title":"Drugs Context"},{"issue":"8","key":"2691_CR29","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.arth.2016.01.038","volume":"31","author":"KL Ong","year":"2016","unstructured":"Ong KL, Anderson AF, Niazi F, Fierlinger AL, Kurtz SM, Altman RD. Hyaluronic acid injections in medicare knee osteoarthritis patients are associated with longer time to knee arthroplasty. J Arthroplasty. 2016;31(8):1667\u201373. https:\/\/doi.org\/10.1016\/j.arth.2016.01.038.","journal-title":"J Arthroplasty"},{"issue":"5","key":"2691_CR30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3111\/13696998.2014.902843","volume":"17","author":"HT Hatoum","year":"2014","unstructured":"Hatoum HT, Fierlinger AL, Lin SJ, Altman RD. Cost-effectiveness analysis of intra-articular injections of a high molecular weight bioengineered hyaluronic acid for the treatment of osteoarthritis knee pain. J Med Econ. 2014;17(5):326\u201337. https:\/\/doi.org\/10.3111\/13696998.2014.902843.","journal-title":"J Med Econ"},{"issue":"8","key":"2691_CR31","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1055\/s-0039-3402043","volume":"34","author":"K Ong","year":"2021","unstructured":"Ong K, Lau E, Runa M, Daley W, Altman R. Factors associated with knee arthroplasty in a knee osteoarthritis patient cohort treated with intra-articular injections of Hylan\u00a0G-F\u00a020. J Knee Surg. 2021;34(8):886\u201397. https:\/\/doi.org\/10.1055\/s-0039-3402043.","journal-title":"J Knee Surg"},{"key":"2691_CR32","doi-asserted-by":"publisher","first-page":"117954412199409","DOI":"10.1177\/1179544121994092","volume":"14","author":"A Concoff","year":"2021","unstructured":"Concoff A, Niazi F, Farrokhyar F, Alyass A, Rosen J, Nicholls M. Delay to TKA and costs associated with knee osteoarthritis care using intra-articular hyaluronic acid: analysis of an administrative database. Clin Med Insights Arthritis Musculoskelet Disord. 2021;14:1179544121994092. https:\/\/doi.org\/10.1177\/1179544121994092.","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"issue":"1","key":"2691_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s12325-019-01142-x","volume":"37","author":"J Rosen","year":"2020","unstructured":"Rosen J, Niazi F, Dysart S. Cost-effectiveness of treating early to moderate stage knee osteoarthritis with intra-articular hyaluronic acid compared to conservative interventions. Adv Ther. 2020;37(1):344\u201352. https:\/\/doi.org\/10.1007\/s12325-019-01142-x.","journal-title":"Adv Ther"},{"issue":"1","key":"2691_CR34","doi-asserted-by":"publisher","first-page":"1586s","DOI":"10.1177\/1947603520967076","volume":"13","author":"MJ Langworthy","year":"2021","unstructured":"Langworthy MJ, Hummer CD, Ngai W, Hao L, Webner D. Evaluation of Hylan\u00a0G-F\u00a020 treatment with opioid prescriptions and intraarticular corticosteroid injections in patients with osteoarthritis of the knee using a claims database. Cartilage. 2021;13(1):1586s\u201397s. https:\/\/doi.org\/10.1177\/1947603520967076.","journal-title":"Cartilage"},{"key":"2691_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/OARRR.S245766","volume":"12","author":"V Khangulov","year":"2020","unstructured":"Khangulov V, Zhang X, Munson SH, Peyerl F, Rey F. Retrospective comparative analysis of opioid use and intra-articular corticosteroid injections before and after initial treatment of knee osteoarthritis with Hylan\u00a0G-F\u00a020. Open Access Rheumatol Res Rev. 2020;12:79\u201385. https:\/\/doi.org\/10.2147\/OARRR.S245766.","journal-title":"Open Access Rheumatol Res Rev"},{"issue":"4","key":"2691_CR36","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/1947603518775792","volume":"10","author":"KL Ong","year":"2019","unstructured":"Ong KL, Runa M, Lau E, Altman R. Is intra-articular injection of Synvisc associated with a delay to knee arthroplasty in patients with knee osteoarthritis? Cartilage. 2019;10(4):423\u201331. https:\/\/doi.org\/10.1177\/1947603518775792.","journal-title":"Cartilage"},{"issue":"12","key":"2691_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145776","volume":"10","author":"R Altman","year":"2015","unstructured":"Altman R, Lim S, Steen RG, Dasa V. Hyaluronic acid injections are associated with delay of total knee replacement surgery in patients with knee osteoarthritis: evidence from a large US health claims database. PLoS ONE. 2015;10(12): e0145776. https:\/\/doi.org\/10.1371\/journal.pone.0145776.","journal-title":"PLoS ONE"},{"issue":"7","key":"2691_CR38","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/joca.2001.0513","volume":"10","author":"GW Torrance","year":"2002","unstructured":"Torrance GW, Raynauld JP, Walker V, et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of Hyalan\u00a0G-F\u00a020 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results. Osteoarthr Cartil. 2002;10(7):518\u201327. https:\/\/doi.org\/10.1053\/joca.2001.0513.","journal-title":"Osteoarthr Cartil"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02691-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02691-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02691-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T12:25:50Z","timestamp":1705580750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02691-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["2691"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02691-y","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]},"assertion":[{"value":"17 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Anil Ranawat received research grant from Enhatch, Conformis, Stryker Corporation, Smith & Nephew, Arthrex, Anika Therapeutics, and Bodycad, outside of the submitted work. Amy Guo is an employee of Ferring Pharmaceuticals. Kaiwen Guo and Faizan Niazi were employees of Ferring Pharmaceuticals when the submitted work was developed. Mark Phillips is an employee of Global Research Solutions Inc. Mohit Bhandari received research grant from Ferring Pharmaceuticals, related to this work, and received research grant from Acumed, Bioventus, DJO Global, Inc, Flexion Therapeutics, Sanofi Aventis, Stryker Corporation, Titan Spine, Inc, BioTraceIT Ltd., AgNovos Health Care and Pendopharm, outside of the submitted work. Brian Waterman has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}